Log in  First Connection?

SchizophreniaArchives

Anodal tDCS over right DLPFC does not improve visuospatial working memory in schizophrenia: a single-session, sham-controlled study
Schizophrenia
 1 min.

 Published on 23/06/2026 |  Original article (Full-text)  | Ke, Shih-Chiang et al. | BMC Psychiatry. Volume 26(1).

Cognitive deficits, particularly in working memory (WM), significantly impair functional outcomes in schizophrenia (SCZ). Transcranial direct current stimulation (tDCS) has shown potential for cognitive enhancement, but its efficacy remains inconsistent. We aimed to evaluate the acute effects of a single-session...

The predictive potential and relationship of peripheral non-enzymatic antioxidants with clinical symptoms in first-episode male adolescent-onset schizophrenia patients
Schizophrenia
 1 min.

 Published on 16/06/2026 |  Original article (Full-text)  | Du, Baolun et al. | Annals of General Psychiatry. Volume 25(1).

Oxidative stress is associated with the pathophysiology of schizophrenia. Peripheral non-enzymatic antioxidants can reflect the degree of oxidative stress and antioxidant levels, and can be used as markers of oxidative stress. However, the relationships between these markers and the clinical phenotypes...

Altered First- but not Higher-Order Motion Aftereffect Strength in Individuals With Schizophrenia
Schizophrenia
 1 min.

 Published on 09/06/2026 |  Original article (Full-text)  | Christophe Delay et al. | Schizophrenia bulletin. Volume 52(2).

Perception integrates sensory input with prior knowledge. Alterations in how both information sources are combined may lead to the departures from consensus reality that characterize schizophrenia (SZ). One source of prior knowledge is recent experience. Visual aftereffects-perceptions of the "opposite"...

The design of multi-target ligands and their role in schizophrenia therapy: an update
Schizophrenia
 1 min.

 Published on 02/06/2026 |  Original article (Full-text)  | Zarko Gagic et al. | Expert opinion on drug discovery 2026; 21(6): 593-608

Schizophrenia is a complex psychiatric disorder with a partially understood pathophysiology involving multiple neurotransmitter systems and receptor families in its onset and progression. Modern therapeutic approaches for effective schizophrenia treatment require multi-target drug actions that exert...